Statement of Changes in Beneficial Ownership (4)
July 12 2017 - 6:14AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
FOSTER JAMES C
|
2. Issuer Name
and
Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL INC
[
CRL
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
Chairman, President and CEO
|
(Last)
(First)
(Middle)
251 BALLARDVALE STREET
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
7/10/2017
|
(Street)
WILMINGTON, MA 01887
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
100
|
D
|
$99.185
|
342298
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
200
|
D
|
$99.19
|
342098
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
100
|
D
|
$99.195
|
341998
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
200
|
D
|
$99.20
|
341798
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
5
|
D
|
$99.205
|
341793
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
912
|
D
|
$99.21
|
340881
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
1
|
D
|
$99.215
|
340880
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
613
|
D
|
$99.22
|
340267
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
200
|
D
|
$99.23
|
340067
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
200
|
D
|
$99.25
|
339867
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
100
|
D
|
$99.255
|
339767
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
100
|
D
|
$99.26
|
339667
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
300
|
D
|
$99.27
|
339367
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
100
|
D
|
$99.28
|
339267
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
99
|
D
|
$99.29
|
339168
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
249
|
D
|
$99.30
|
338919
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
40
|
D
|
$99.315
|
338879
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
700
|
D
|
$99.32
|
338179
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
101
|
D
|
$99.33
|
338078
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
300
|
D
|
$99.37
|
337778
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
100
|
D
|
$99.395
|
337678
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
100
|
D
|
$99.40
|
337578
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
300
|
D
|
$99.41
|
337278
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
100
|
D
|
$99.42
|
337178
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
100
|
D
|
$99.54
|
337078
|
D
|
|
Common Stock
|
7/10/2017
|
|
S
(1)
|
|
400
|
D
|
$99.62
|
336678
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(1)
|
This sale occurred pursuant to a 10b5-1 Trading Plan.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
FOSTER JAMES C
251 BALLARDVALE STREET
WILMINGTON, MA 01887
|
X
|
|
Chairman, President and CEO
|
|
Signatures
|
/s/ James C. Foster
|
|
7/10/2017
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Apr 2024 to May 2024
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From May 2023 to May 2024